Since the Trust began in 1996 we have awarded over 50 grants. Our awards have ranged from a few hundred pounds to cover travel costs to £638,000 for the support of a programme grant. We support both basic science and applied medical research and strongly encourage collaboration between our researchers.
Key target areas for funding
The CGD Research Trust funds research into the cause, inheritance, diagnosis, management and treatment of CGD. It is willing to consider research applications of high quality, to address important scientific, clinical or social questions relating to CGD. There are no geographical restrictions concerning the allocation of funding. The criteria for funding are excellent science and relevance to and benefit for CGD. All clinical and research projects are subjected to full peer review and are scrutinised by a panel of medical and scientific experts.
Read more about our research strategy here.
The CGD Research Trust is committed to provide funding in the following areas:
- Gene Therapy
Since the identification of one of the genes that causes CGD in 1986, research is increasingly focused on correcting the genetic defect by gene therapy. This may provide a treatment option for individuals affected by CGD when bone marrow transplantation is not a viable option.
Read More... - Basic research concerning the structure and function of the enzyme NADPH oxidase and identification of possible target pathways for therapeutic intervention. Improvement of diagnosis for variant CGD.
Read More... - Mechanisms of inflammation leading to granuloma formation and inflammatory bowel disease. The use of anti-inflammatory agents to treat inflammatory problems in CGD.
Read More... - Causes of infection in CGD with particular reference to Aspergillus; the mechanisms involved and improving methods of treatment.
Read More... - The CGD Registries
A 'snapshot' picture of the incidence of CGD in the UK and Europe has been now obtained. The database provides detailed information on the course of the disease, and will further our understanding of the prevalence of the condition and lead to the improvement in diagnosis, treatment and prevention of the clinical complications that can occur in CGD.
Read More...
How Our Research Income is Spent
Our research investment is in a number of key areas that are important to finding a cure for CGD and tackling problems that affect CGD patients. This pie chart gives the proportion of our research income invested in different research areas (1996 - 2006).
IMPORTANT NOTE :
The information contained on this website is intended only as a guideline, not as a substitute for medical advice. Always consult your doctor if you or your child has any CGD symptoms or concerns.
© 2001-2007 The Chronic Granulomatous Disorder (CGD) Research Trust
Registered Charity No. 1003425 email:cgd@cgdrt.co.uk
The CGD Research Trust is a member of the Association of Medical Research Charities (AMRC), the Genetic Interest Group (GiG) and an associate member of the International Patient Organisation of Primary Immunodeficiencies (IPOPI)
Site Map | Terms and Conditions | Privacy
